TABLE 2.
Zn+MVs (n = 602) | Zinc only (n = 596) | Multivitamins only (n = 598) | Placebo (n = 604) | |
Change in HAZ | −0.79 ± 0.05 | −0.93 ± 0.05 | −0.88 ± 0.05 | −0.93 ± 0.05 |
P | 0.058 | 0.956 | 0.478 | Referent |
Change in WAZ | −0.36 ± 0.04 | −0.61 ± 0.04 | −0.52 ± 0.04 | −0.50 ± 0.04 |
P | 0.020 | 0.063 | 0.792 | Referent |
Change in WHZ | −0.31 ± 0.07 | −0.57 ± 0.07 | −0.42 ± 0.07 | −0.35 ± 0.07 |
P | 0.655 | 0.021 | 0.473 | Referent |
All values are mean ± SEs. The analysis was derived from a mixed-effects model with restricted cubic splines. P values are for comparisons of the mean change in z score compared with the mean change in z score in the placebo group. HAZ, height-for-age z score; WAZ, weight-for-age z score; WHZ, weight-for-height z score; Zn+MV, zinc and multivitamin.